A Safety Comparison of Metformin vs Sulfonylurea Initiation in Patients With Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Cohort Study
To compare the safety of metformin vs sulfonylureas in patients with type 2 diabetes by chronic kidney disease (CKD) stage.
Source: Mayo Clinic Proceedings - Category: Internal Medicine Authors: Reid H. Whitlock, Ingrid Hougen, Paul Komenda, Claudio Rigatto, Kristin K. Clemens, Navdeep Tangri Tags: Original article Source Type: research
More News: Chronic Kidney Disease | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Internal Medicine | Metformin | Study | Urology & Nephrology